Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
-
Canaccord Genuity on Pharmasset (VRUS): Acquisition Validates Power of Nuc Prodrugs
-
Canaccord Genuity on Specialty Pharmaceuticals: Top Catalyst-Driven Stocks with Potential for Upside by Year-End
-
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); New 7-day Data Significantly Mitigates 189 Risk
-
Canaccord Genuity Reiterates a 'Buy' on Pharmasset (VRUS); PH 3 Plans in Place
-
Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Big Catalysts Expected Over Next 12 Months
-
Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Looking to 2012 for Read-outs From Lead HCV
-
Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Anticipation of HCV Pipeline Advancement
-
Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Q1/11: Readying for INX-189 Phase II Trials
-
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); New 7-Day Data Support INX-189 Potential
-
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); Notes From the Road; Valuation Inflection Point Nears
-
UPDATE - Canaccord Genuity Initiates Coverage on Inhibitex (INHX) with a Buy; Two Hot Nucs - One For HCV and One For Shingles
-
Canaccord Genuity Starts Inhibitex (INHX) at Buy
